SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,774,808 | +926.6% | 3,105,132 | +1275.7% | 0.02% | +1100.0% |
| Q2 2023 | $1,049,598 | +307.7% | 225,720 | +305.1% | 0.00% | +100.0% |
| Q1 2023 | $257,426 | -89.2% | 55,720 | -65.2% | 0.00% | -75.0% |
| Q4 2021 | $2,381,000 | -54.2% | 160,000 | -41.8% | 0.00% | -60.0% |
| Q3 2021 | $5,195,000 | -14.0% | 275,000 | -15.4% | 0.01% | -16.7% |
| Q2 2021 | $6,042,000 | -41.0% | 325,000 | -27.8% | 0.01% | -42.9% |
| Q1 2021 | $10,249,000 | -0.6% | 450,300 | -5.2% | 0.02% | -4.5% |
| Q4 2020 | $10,312,000 | +41.5% | 475,000 | -34.5% | 0.02% | +22.2% |
| Q3 2020 | $7,286,000 | +29.5% | 725,000 | 0.0% | 0.02% | +28.6% |
| Q2 2020 | $5,626,000 | +29.8% | 725,000 | +70.6% | 0.01% | +7.7% |
| Q1 2020 | $4,335,000 | +1476.4% | 425,000 | +1600.0% | 0.01% | +1200.0% |
| Q4 2019 | $275,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |